Fomite

52 ms·

781.
by Fomite 5y ago
My institution employs about 7000 people. I'm interested if there's a single company that employs that many people you can point to that pays $0 to handle payroll.
782.
by Fomite 5y ago
While "huge startup package" varies wildly - epidemiologists are cheap, for example, you are by and large correct. The data center where my nodes for HPC are kept? Indirects. The salary of the folks who review and submit the propo
783.
by Fomite 5y ago
It's 69%, so you were...close I guess? https://osp.finance.harvard.edu/files/univ_july_2021_signed_...
784.
by Fomite 5y ago
53% is both not particularly that high and not unusual. Keep in mind that in private industry, that stuff is built into the price. I've also seen the indirect rates for several private research firms - they're higher. I think the
785.
by Fomite 5y ago
This. A mentor of mine is able to fund most of her students, save for maybe their final year, on TA-shps. I'm in a purely research department - if I don't have funding for the full time, I don't have students.
786.
by Fomite 5y ago
MIT is 55% Stanford is 58% The only place I've ever encountered with an overhead rate above 100% was Scripps, and that's because they have to maintain research vessels.
787.
by Fomite 5y ago
A couple notes: - As mentioned by several people, your math is a little off, and indirects are not a flat tax, there's a calculation for what is eligible for being charged indirect costs and at what rate. - The CAREER award is prestigi
788.
by Fomite 5y ago
Having been both a grant writer and a reviewer for NIH and NIH-alike grants, there's an element of both. Established groups definitely get a bit of a pass with "Well, surely Professor So-and-So will sort this out" that an ear
789.
by Fomite 5y ago
In contrast, ours focused almost entirely on polishing and refining our specific aims page. Eight weeks on what was effectively perhaps two pages of writing. Draft after draft, peer review, etc. Landed said grant on first submission.
790.
by Fomite 5y ago
Or more generally, an aggressive move away from using p-values in some fields.
791.
by Fomite 5y ago
Cash tipping can also fall into this, and is hardly an obscure corner case.
792.
by Fomite 5y ago
"I did not realize it matters whether you're "in the field" or not, thinking that good contributions are welcomed equally as being good contributions." It's not necessarily 'in the field' - I, for exa
793.
by Fomite 5y ago
Honestly, as a researcher in another field who on occasion gets asked to "audit" people's thoughts, it's a return on investment problem. Doing something carefully enough to actually be worthwhile is (especially for someo
794.
by Fomite 5y ago
https://www.medrxiv.org/content/10.1101/2021.10.05.21264581v...
795.
by Fomite 5y ago
Risk decreases over time, but the distribution of time-until-recovery is longer than one might hope.
796.
by Fomite 5y ago
Epidemiologically, endemic is that the rates of disease are within expectation - for example, there's a statistical threshold for flu every year. There can still be swings - seasonal diseases for example. There is no sane universe wher
797.
by Fomite 5y ago
Norovirus is just bonkers.
798.
by Fomite 5y ago
My biggest concern is the studies that have been comparing myocarditis induced by the vaccine vs. those with MIS-C from COVID-19 that show that they're not necessarily directly comparable - the vaccine-induced version is also milder. I
799.
by Fomite 5y ago
While there are several problems with that paper, it should be noted, as an epidemiologist, that the publication timelines for COVID-19 papers have gone well and truly pear shaped.
800.
by Fomite 5y ago
Immunity can be boosted through exposure (indeed, this is one of the reasons why we may be seeing higher rates of shingles in young people, or why we see occasional outbreaks of pertussis in people who were vaccinated awhile back). But for
801.
by Fomite 5y ago
Happy to expand on it if you wish.
802.
by Fomite 5y ago
It's a long way down the road, but if you're ever interested in funding university-based research (in the US): Universities have something called an indirect rate. This is basically how they pay for things that a private company w
803.
by Fomite 5y ago
I've signed a couple, but they've all been due to working with private industry.
804.
by Fomite 5y ago
They're not exactly going to go quietly into the night with an attempt to "blow it up" either.
805.
by Fomite 5y ago
On the other hand, to those who did need them, they were potentially invaluable.
806.
by Fomite 5y ago
I work with a lot of clinicians. Normal flu seasons don't leave them with 1000 yard stares.
807.
by Fomite 5y ago
"Politicians who want to require open access journals for govt funded work?" Not this one. The open access requirements tend to be a year's delay and then it's open access at no cost.
808.
by Fomite 5y ago
This. 11K would be a full tenth of the discretionary money I got for my startup package. The paper would be a sweet get, but this is definitely a "Rich labs get papers in Nature journals, get better grants and become richer labs...&q
809.
by Fomite 5y ago
While I normally defend publishing fees fairly actively, $11K is uncalled for.
810.
by Fomite 5y ago
I always build one open access publication into my grant budgets - but $11K is way above what's normal.

More ›